Arimidex 1 - Beligas Pharmaceuticals

A non-steroidal aromatase inhibitor, Anastrozole gained FDA approval in the 1990s to support postmenopausal breast cancer patients. Athletes seeking lean muscle often use it to counteract estrogenic effects from steroids, benefiting from its stronger estrogen suppression compared to tamoxifen. It allows for greater muscle definition while minimizing water retention. However, it also lowers HDL cholesterol, requiring users to monitor their cardiovascular health, especially with prolonged cycles​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Arimidex 1 by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.